1 / 20

Mechanisms of tolerance & models of Dependence

Mechanisms of tolerance & models of Dependence. Tolerance. Definition: Diminished drug effectiveness or potency resulting from repeated (chronic) use. Decreased efficacy Downward shift Decreased potency Rightward shift. Cross Tolerance.

masao
Download Presentation

Mechanisms of tolerance & models of Dependence

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Mechanisms of tolerance & models of Dependence

  2. Tolerance • Definition: Diminished drug effectiveness or potency resulting from repeated (chronic) use. • Decreased efficacy • Downward shift • Decreased potency • Rightward shift

  3. Cross Tolerance • When tolerance to one drug diminishes the effects of another drug • Often observed between members of same drug class • All opiates display cross-tolerance • Alcohol may exhibit cross-tolerance with other substances with similar pharmacological actions, such as the benzodiazepines (e.g., Valium, Xanax)

  4. Mechanisms of Tolerance • Metabolic (dispositional) Tolerance • e.g., Alcohol and barbiturates increased liver enzyme activity. • e.g., Amphetamine alters urine pH, making it more acidic, which increases excretion of amphetamine. • Physiological (pharmacodynamic, cellular) Tolerance • e.g., receptor affinity or number altered by drug actions • disruption of homeostatic processes may be critical • Behavioral Tolerance • Learning to compensate for drug-induced impairments • respondent or operant conditioning

  5. Physical Dependence • Withdrawal symptoms • Physiological changes when chronic drug use is stopped • Particular withdrawal symptoms depend on the drug • Opiate withdrawal: flulike symptoms • Alcohol withdrawal: DTs, possible seizures • Many drugs do not produce PHYSICAL dependence • Drugs with similar actions tend to produce similar withdrawal symptoms • Cross Dependence • Drugs with similar actions will alleviate withdrawal symptoms from another drug. • e.g., methadone for heroin dependence, benzodiazepines for alcohol dependence

  6. Tolerance and Respondent Conditioning • Respondent Conditioning of Drug Effects • Pavlov’s early work with apomorphine • Conditioned Compensatory Responses • the CR may not be opposite the UR • The body’s attempts to resist the drug’s effects, rather than the drug effects themselves may be what are conditioned. • Siegel’s research on respondent conditioning of tolerance to the analgesic effects of morphine in rats.

  7. Tolerance and Respondent Conditioning • Conditioned Compensatory Responses • May be difficult to extinguish • May persist long after physical withdrawal symptoms no longer evident • Environmental cues may contribute to relapse

  8. Tolerance and Operant Conditioning • Campbell and Seiden (1973) • Tolerance to amphetamine in rats treated prior to DRL training sessions, not after. • Schuster et al. (1966) • Tolerance did not develop to rate-increasing effects of amphetamine on an FI schedule. • Vogel-Sprott (1992) • role of reinforcement in conditioned tolerance to alcohol in humans

  9. Sensitization • Enhance effects of drug following repeated exposure • Less common than tolerance • Most often studied in nonhuman species • Activating effects of drugs • Conditioned sensitization • Cross sensitization

  10. Models of Addiction • Disease Model • Physical Dependence Model • Positive Reinforcement Model

  11. Disease Model • Historical Background • Social reform of the 19th century • AA movement of the mid-20th century • Potential Strengths of Disease Model • Considers addictive behavior abnormal • Explains why only some develop addiction • Implications for Therapy vs. Punishment

  12. Disease Model • Problems/Limitations of Disease Model • Mechanisms not well understood • Accepting “loss of control” as an explanation may reduce the addicts accountability • Characterizing addiction as a disease • Predisposition Theories • Exposure Theories • Acceptance/rejection of the disease model depends on the definition of “disease”, more so than an understanding of mechanisms responsible for addiction.

  13. Physical Dependence Model • Historical Background • Drug seeking motivated by fear of severe withdrawal symptoms. • What about drugs that don’t produce physical dependence? • Defining Psychological Dependence • Problems/Limitations Dependence Theories of Addiction

  14. Positive Reinforcement Model • Modern Behavioral Neuroscience Explanation for Addiction • Based on key findings that many drugs can be established as positive reinforcers • Problems with Positive Reinforcement Model

  15. Drug Self-Administration • Similarities/Differences Between Human and Nonhuman Species • Type of Drug • Most psychoactive drugs that are abused by humans are also self-administered by nonhumans. • Some drugs (e.g., LSD) are not self-administered by nonhumans. • Patterns of Self-Administration • Patterns of use are comparable between humans and monkeys (see figure 5-2)

  16. Measuring Reinforcing Value of Drugs • Rate: not an ideal measure • Progressive Ratio Schedules • Concurrent Schedules (choice) • Place Conditioning Procedures

  17. Factors that Modulate Reinforcing Value of Drugs • Dose Effects • Genetic Differences • Task Demands • Stress • Previous Drug Experience

  18. Neuroanatomy of Motivation/Reinforcement • Olds and Milner (1954) • Median Forebrain Bundle • Mesolimbic Dopamine Pathways • VTA -> Nucleus Accumbens

  19. Incentive Sensitization Theory • Robinson and Berridge (1993) • A model to explain drug craving • Craving is conceptualized as a manifestation of incentive salience, which becomes stronger with repeated drug use due to the sensitization of the mesolimbic dopamine system to drug effects. • Repeated presentation of a reinforcer causes the stimuli associated with it to also have greater incentive salience. • Repeated use of a drug increases its reinforcing value and its capacity to control behavior.

  20. Behavioral Economics • Matching Law • Price and Demand • Marilyn Carroll (1993) • Generated demand curves from studies of PCP consumption under different FR ratio schedules in rhesus monkeys

More Related